Masataka Ohta Selected Research

Drug Eruptions (Drug Eruption)

1/2018	The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation.
1/2017	Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masataka Ohta Research Topics

Disease

2	Drug Eruptions (Drug Eruption) 01/2018 - 01/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Hypersensitivity (Allergy) 10/2015
1	Catatonia 01/2006
1	Parkinsonian Disorders (Parkinsonism) 01/2006
1	Carcinoma (Carcinomatosis) 11/2002
1	Metaplasia 11/2002

Drug/Important Bio-Agent (IBA)

3	Chemokine CCL17IBA 01/2018 - 10/2015
1	C-Reactive ProteinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2006
1	Immunoglobulin G (IgG)IBA 11/2002
1	Monoclonal AntibodiesIBA 11/2002
1	EpitopesIBA 11/2002
1	CarbohydratesIBA 11/2002
1	Coloring Agents (Dyes)IBA 11/2002
1	high iron diamine-alcian blueIBA 11/2002
1	MucinsIBA 11/2002
1	Peptides (Polypeptides)IBA 11/2002